Background: Catheter ablation (CA) effectively treats atrial fibrillation (AF) in heart failure (HF) with reduced ejection fraction (HFrEF), improving clinical outcomes. However, its benefits for AF patients with heart failure with preserved ejection fraction (HFpEF) are still unclear.
Methods: We systematically searched PubMed, Embase, Web of Science, the Cochrane Library, and Scopus for studies investigating outcomes of CA in AF patients with HFpEF.
ACS Appl Mater Interfaces
April 2024
Unique active sites make single-atom (SA) catalysts promising to overcome obstacles in homogeneous catalysis but challenging due to their fixed coordination environment. Click chemistry is restricted by the low activity of more available Cu(II) catalysts without reducing agents. Herein, we develop efficient, O-coordinated SA Cu(II) directly catalyzed click chemistry.
View Article and Find Full Text PDFEar Nose Throat J
November 2024
Hamartomas, as non-true tumors, are commonly found in the lungs, digestive tract, and kidneys, and there are few clinical reports on nasal cases. Nasal histiocytosis accompanied by lymphatic lesions is a common feature of nasal hamartoma. Three patients with nasal cavity hamartoma were treated in our department, including 1 male and 2 females, with nasal obstruction or epistaxis.
View Article and Find Full Text PDFSingle-atom (SA) catalysts have attracted broad attention due to their distinctive catalytic properties in diverse reactions. Increasing the unsaturated coordination sites of active centers is a valid and challenging approach to improve the performance of such catalysts. Herein, we report an oxide compounding strategy to decrease the N coordination number of a SA Cu catalyst by reducing the thickness of the N-doped carbon carrier with a lower density of N atoms.
View Article and Find Full Text PDF